Alyra Biotech
PrivateLast Round
Grant
Sep 16, 2025
Total Funding Raised
$560,000
Company Overview
Alyra Biotech is a biopharmaceutical company that develops novel, immune-modulating intrauterine devices to treat neuroimmune conditions and chronic pelvic pain in women.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alyra Biotech Comparables
Compare Alyra Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OCON Therapeutics | 76% | |
| EndoCyclic Therapeutics | 72% | |
| AbbVie | 62% |
Alyra Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 16, 2025 | ||||
| Grant | Mar 5, 2025 | ||||
| Grant | Jul 20, 2022 |
Key People
Founding team and executive leadership
Alyra Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Equiter S.p.A. | Grant |
| South Australia Government | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 42% MoM, reaching 1.8K.
- Mar 2, 2026
Monthly visitors increased 313% MoM.
Alyra Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alyra Biotech's valuation, stock price, and market status.
Is Alyra Biotech a public or private company?
Alyra Biotech is a private company.
What is the current stock price of Alyra Biotech?
Alyra Biotech is a private company with no public stock price. Caplight tracks Alyra Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Alyra Biotech worth (valuation)?
Valuation information for Alyra Biotech is not publicly available.
Can I buy Alyra Biotech stock?
Alyra Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alyra Biotech's last funding round?
Alyra Biotech's most recent funding round was Grant on September 16, 2025.
Who are the main investors in Alyra Biotech?
Key investors in Alyra Biotech include Equiter S.p.A., South Australia Government.
Will Alyra Biotech IPO soon?
No public IPO plans have been announced for Alyra Biotech.
How can I track Alyra Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alyra Biotech's secondary market activity and sign up for updates.